Discover 1,558 paid clinical trials in Boulder, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,558
Featured
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
Location: 35 recruiting locations
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase3, Recruiting
Active & Responsive
Safety and Efficacy of FT218 in Idiopathic Hypersomnia (REVITALYZ)
for
Idiopathic Hypersomnia
Location: 7 recruiting locations
Sponsor: Avadel
Sex: All
Age: 18 - 70+
Code: NCT06525077
Phase3, Recruiting
Active & Responsive
5-Years PMCF Study of Ceramic Dental Implants One-piece Versus Two-piece.
for
Edentulism, Tooth Loss
Location: 1 recruiting location
Sponsor: CeraRoot SL
Sex: All
Age: 18+
Code: NCT06287346
Recruiting
Active & Responsive
Perceptual Influences From Smoking Cannabis: an Experimental Study
for
Cannabis Use, Stress
Location: 1 recruiting location
Sponsor: University of Colorado, Boulder
Sex: All
Age: 21 - 65
Code: NCT06588582
Recruiting
Active & Responsive
WATER IV Prostate Cancer
for
Localized Prostate Cancer
Location: 24 recruiting locations
Sponsor: PROCEPT BioRobotics
Sex: Male
Age: 45+
Code: NCT06651632
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain
for
Obesity, Overweight, Chronic Low Back Pain (CLBP)
Location: 30 recruiting locations
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07035093
Phase3, Recruiting
Active & Responsive
National Cancer Institute "Cancer Moonshot Biobank"
for
Acute Myeloid Leukemia,
Location: 109 recruiting locations
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 13+
Code: NCT04314401
Recruiting
Active & ResponsiveNew
A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)
for
SARS-CoV-2
Location: 128 recruiting locations
Sponsor: ModernaTX, Inc.
Sex: All
Age: 50 - 64
Code: NCT07266558
Recruiting
Active & Responsive
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer